U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Laws Enforced by FDA
  4. Federal Food, Drug, and Cosmetic Act (FD&C Act)
  5. FD&C Act Chapter V: Drugs and Devices
  1. Federal Food, Drug, and Cosmetic Act (FD&C Act)

FD&C Act Chapter V: Drugs and Devices

To search the FD&C Act on the Law Revision Counsel website, you may either search by U.S. code section number or browse the Title 21 section listing.

Part A - Drugs and Devices (sections 351 - 360n-1)

FD&C Act Section Number Title
Sec. 501 Sec. 351 - Adulterated drugs and devices
Sec. 502 Sec. 352 - Misbranded drugs and devices
Sec. 503 Sec. 353 - Exemptions and consideration for certain drugs, devices, and biological products
Sec. 503A Sec. 353a - Pharmacy compounding
Sec. 503A-1 Sec. 353a-1 - Enhanced Communication
Sec. 503B Sec. 353b - Outsourcing facilities
Sec. 503C Sec. 353c - Prereview of television advertisements
Sec. 504 Sec. 354 - Veterinary feed directive drugs
Sec. 505 Sec. 355 - New drugs
  Sec. 355-1 - Risk evaluation and mitigation strategies
Sec. 505A Sec. 355a - Pediatric studies of drugs
  Sec. 355b - Adverse-event reporting
Sec. 505B Sec. 355c - Research into pediatric uses for drugs and biological products
  Sec. 355c-1 - Report
Sec. 505C Sec. 355d - Internal committee for review of pediatric plans, assessments, deferrals, and waivers
Sec. 505D Sec. 355e - Pharmaceutical security
Sec. 506 Sec. 356 - Fast track products
  Sec. 355f - Extension of exclusivity period for new qualified infectious disease products
  Sec. 356. Expedited approval of drugs for serious or life-threatening diseases or conditions
  Sec. 356-1 - Accelerated approval of priority countermeasures
Sec. 506A Sec. 356a - Manufacturing changes
Sec. 506B Sec. 356b - Reports of postmarketing studies
Sec. 506C Sec. 356c - Discontinuance or interruption in the production of life-saving drugs
  Sec. 356c-1 - Annual reporting on drug shortages
  Sec. 356d - Coordination; task force and strategic plan
  Sec. 356e - Drug shortage list
  Sec. 356f - Hospital repackaging of drugs in shortage
  Sec. 357 - Repealed. Pub. L. 105-115, title I, §125(b)(1), Nov. 21, 1997, 111 Stat. 2325
Sec. 508 Sec. 358 - Authority to designate official names
Sec. 509 Sec. 359 - Nonapplicability of subchapter to cosmetics
Sec. 510 Sec. 360 - Registration of producers of drugs or devices
Sec. 511 Sec. 360a - Clinical trial guidance for antibiotic drugs
  Sec. 360a-1 - Clinical trials
Sec. 512 Sec. 360b - New animal drugs
Sec. 513 Sec. 360c - Classification of devices intended for human use
  Sec. 360c-1 - Reporting
Sec. 514 Sec. 360d - Performance standards
Sec. 515 Sec. 360e - Premarket approval
Sec. 515A Sec. 360e-1 - Pediatric uses of devices
Sec. 516 Sec. 360f - Banned devices
Sec. 517 Sec. 360g - Judicial review
  Sec. 360g-1. Agency documentation and review of significant decisions regarding devices
Sec. 518 Sec. 360h - Notification and other remedies
  Sec. 360h-1. Program to improve the device recall system
Sec. 519 Sec. 360i - Records and reports on devices
Sec. 520 Sec. 360j - General provisions respecting control of devices intended for human use
Sec. 521 Sec. 360k - State and local requirements respecting devices
Sec. 522 Sec. 360l - Postmarket surveillance
Sec. 523 Sec. 360m - Accredited persons
Sec. 524 Sec. 360n - Priority review to encourage treatments for tropical diseases
  Sec. 360n-1. Priority review for qualified infectious disease products

Part B - Drugs for Rare Diseases or Conditions (sections 360aa - 360ff)

FD&C Act Section Number Title
Sec. 525 Sec. 360aa - Recommendations for investigations of drugs for rare diseases or conditions
Sec. 526 Sec. 360bb - Designation of drugs for rare diseases or conditions
Sec. 527 Sec. 360cc - Protection for drugs for rare diseases or conditions
Sec. 528 Sec. 360dd - Open protocols for investigations of drugs for rare diseases or conditions
  Sec. 360ee - Grants and contracts for development of drugs for rare diseases and conditions
  Sec. 360ff - Priority review to encourage treatments for rare pediatric diseases

Part C - Electronic Product Radiation Control (sections 360hh - 360ss)

FD&C Act Section Number Title
Sec. 531 Sec. 360hh - Definitions
Sec. 532 Sec. 360ii - Program of control
Sec. 533 Sec. 360jj - Studies by Secretary
Sec. 534 Sec. 360kk - Performance standards for electronic products
Sec. 535 Sec. 360ll - Notification of defects in and repair or replacement of electronic products
Sec. 536 Sec. 360mm - Imports
Sec. 537 Sec. 360nn - Inspection, records, and reports
Sec. 538 Sec. 360oo - Prohibited acts
Sec. 539 Sec. 360pp - Enforcement
  Sec. 360qq - Repealed. Pub. L. 105-362, title VI, §601(a)(2)(A), Nov. 10, 1998, 112 Stat. 3285
Sec. 541 Sec. 360rr - Federal-State cooperation
Sec. 542 Sec. 360ss - State standards

Part D - Dissemination of Treatment Information (sections 360aaa - 360aaa-6)

FD&C Act Section Number Title
  Secs. 360aaa to 360aaa-6 - Omitted

Part E - General Provisions Relating to Drugs and Devices (sections 360bbb - 360bbb-8c)

FD&C Act Section Number Title
Sec. 561 Sec. 360bbb - Expanded access to unapproved therapies and diagnostics
Sec. 652 Sec. 360bbb-1 - Dispute resolution
Sec. 563 Sec. 360bbb-2 - Classification of products
Sec. 564 Sec. 360bbb-3 - Authorization for medical products for use in emergencies
  Sec. 360bbb-3a - Emergency use of medical products
  Sec. 360bbb-3b - Products held for emergency use
Sec. 565 Sec. 360bbb-4 - Countermeasure development, review, and technical assistance
Sec. 566 Sec. 360bbb-5 - Critical Path Public-Private Partnerships
Sec. 567 Sec. 360bbb-6 - Risk communication
  Sec. 360bbb-7 - Notification
  Sec. 360bbb-8 - Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments
  Sec. 360bbb-8a - Optimizing global clinical trials
  Sec. 360bbb-8b - Use of clinical investigation data from outside the United States
 
  Sec. 360bbb-8c - Patient participation in medical product discussion

Part F - New Animal Drugs for Minor Use and Minor Species (sections 360ccc - 360ccc-2)

FD&C Act Section Number Title
Sec. 571 Sec. 360ccc - Conditional approval of new animal drugs for minor use and minor species
Sec. 572 Sec. 360ccc-1 - Index of legally marketed unapproved new animal drugs for minor species
Sec. 573 Sec. 360ccc-2 - Designated new animal drugs for minor use or minor species

Part G - Medical Gases (sections 360ddd to 360ddd-2)

FD&C Act Section Number Title
  Sec. 360ddd - Definitions
  Sec. 360ddd-1 - Regulation of medical gases
  Sec. 360ddd-2 - Inapplicability of drug fees to designated medical gases

Part H - Pharmaceutical Distribution Supply Chain (sections 360eee to 360eee-4)

FD&C Act Section Number Title
  Sec. 360eee - Definitions
  Sec. 360eee-1 - Requirements
  Sec. 360eee-2 - National standards for prescription drug wholesale distributors
  Sec. 360eee-3 - National standards for third-party logistics providers
  Sec. 360eee-4 - Uniform national policy

Part I—Nonprescription Sunscreen and Other Active Ingredients (sections 360fff to 360fff-7)

FD&C Act Section Number Title
  Sec. 360fff - Definitions
  Sec. 360fff-1 - Submission of requests
  Sec. 360fff-2 - Eligibility determinations; data submission; filing
  Sec. 360fff-3 - GRASE determination
  Sec. 360fff-4 - Guidance; other provisions
  Sec. 360fff-5 - Sunscreen monograph
  Sec. 360fff-6 - Non-sunscreen time and extent applications
  Sec. 360fff-7 - Report

 



Back to Top